Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers

Status:	Completed
Conditions:	Gastrointestinal, Podiatry, Diabetes
Therapuetic Areas:	Endocrinology, Gastroenterology, Orthopedics / Podiatry
Healthy:	No
Age Range:	18 - Any
Updated:	4/2/2016
Start Date:	January 2006
End Date:	September 2009
Contact:	M Meek
Email:	clinicaltrial@keracure.com
Phone:	866-537-2287

A Prospective, Randomized, Controlled, Unmasked, Multiple Treatment, Multi-Center Clinical Trial to Evaluate the Efficacy and Safety of an Interactive Wound Dressing Containing Cultured Keratinocytes Versus Conventional Wound Therapy for the Treatment of Diabetic Foot Ulcers

The objective of this study is to determine the safety and effectiveness of a device (the
KC-002 interactive wound dressing) in the promotion of healing in diabetic foot ulcers as
compared with a conventional wound therapy regimen for subjects with Type 1 or Type 2
diabetes mellitus.

This is a prospective, randomized, multi-center, unmasked, controlled study. All patients
will receive care for the diabetic foot ulcer during the study.

Participation in the study is for 24 weeks.

Inclusion Criteria:

Participants included in the study must:

- Have Type 1 or Type 2 diabetes mellitus

- Have a diabetic foot ulcer on the bottom of the foot or heal which has been present
for three (3) weeks but less than two (2) years and is sufficient size to qualify for
the study

- Be able to visit the study doctor regularly for 24 weeks

Exclusion Criteria:

Participants may not be included if:

- The diabetic foot ulcer is infected

- They have poor circulation in their study foot

- Cannot or will not wear a special boot to take pressure off the study ulcer

- They have certain other diseases or laboratory values which are not within a
specified range

We found this trial at

sites

Sinai Hospital of Baltimore

2401 W Belvedere Ave
Baltimore, Maryland 21215

(410) 601-9000